AggarwalSK, et al.: Clearing the air: What the latest Supreme Court decision regarding medical marijuana really means. Am J Hosp Palliat Care, 2005; 22:327–329.
AggarwalSK: Cannabinergic pain medicine: A concise clinical primer and survey of randomized-controlled trial results. Clin J Pain, 2013; 29:162–171.
5.
GW Pharma: Special warnings and precautions for use In: Summary of Product Characteristics: Sativex Oromucosal Spray. GW Pharma, Wiltshire, England, 2012.
6.
DavisonSN, et al.: Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease?. J Pain Symptom Manage, 2011; 41:768–778.
7.
HazekampA, RuhaakR, ZuurmanL, van GervenJ, VerpoorteR: Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol. J Pharm Sci, 2006; 95:1308–1317.
8.
ElvikR: Risk of road accident associated with the use of drugs: A systematic review and meta-analysis of evidence from epidemiological studies. Accid Anal Prev, 2013; 60:254–267.
9.
Advisory Council on the Misuse of Drugs: Further consideration of the classification of cannabis under the Misuse of Drugs Act 1971. London: Home Office, 2005.
10.
Advisory Council on the Misuse of Drugs: Cannabis: Classification and public health. London: Home Office, 2008.
11.
HazekampA, GrotenhermenF: Review on clinical studies with cannabis and cannabinoids 2005–2009. Cannabinoids, 2010; 5:1–21.
12.
CarterGT, et al.: Cannabis in palliative medicine: Improving care and reducing opioid-related morbidity. Am J Hosp Palliat Care, 2011; 28:297–303.
13.
ShaiovaL, et al.: Cancer pain: Principles of assessment and syndromes. In: BergerAM, ShusterJL, Von RoennJH (eds): Principles and Practice of Palliative Care and Supportive Oncology, 4th ed. Philadelphia, PA. Lippincott Williams & Wilkins, 2013.
14.
AggarwalSK, et al.: Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State. J Opioid Manag, 2009; 5:257–286.
15.
AggarwalSK, et al.: Prospectively surveying health-related quality of life and symptom relief in a lot-based sample of medical cannabis-using patients in urban Washington State reveals managed chronic illness and debility. Am J Hosp Palliat Care, 2013; 30:523–531.
16.
PortenoyRK, et al.: Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: A randomized, placebo-controlled, graded-dose trial. J Pain, 2012; 13:438–449.
17.
ChangAE, et al.: Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate: A prospective, randomized evaluation. Ann Intern Med, 1979; 91:819–824.
18.
ChangAE, et al.: A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy. Cancer, 1981; 47:1746–1751.
19.
LevittM, et al.: Randomized double-blind comparison of delta-9-tetrahydrocannabinol and marijuana as chemotherapy antiemetics. Proc Am Soc Clin Oncol, 1984; 3:91(abstr C-354).
20.
ZajicekJ, et al.: Cannabinoids in multiple sclerosis (CAMS) study: Safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry, 2005; 76:1664–1669.
21.
AbramsDI, et al.: Short-term effects of cannabinoids in patients with HIV-1 infection. Ann Intern Med, 2003; 139:258–266.
22.
HaneyM, et al.: Dronabinol and marijuana in HIV+ marijuana smokers: Acute effects on caloric intake and mood. Psychopharmacology, 2005; 181:170–178.
23.
HaneyM, et al.: Dronabinol and marijuana in HIV-positive marijuana smokers. J Acquir Immune Defic Syndr, 2007; 45:545–554.
24.
AbramsDI, et al.: Cannabis in painful HIV-associated sensory neuropathy. Neurology, 2007; 68:515–521.
25.
EllisRJ, et al.: Smoked medicinal cannabis for neuropathic pain in HIV: A randomized, crossover clinical trial. Neuropsychopharmacology, 2009; 34:672–680.
26.
PhillipTJ, et al.: Pharmacological treatment of painful HIV-associated sensory neuropathy: A systematic review and meta-analysis of randomised controlled trials. PLoS One, 2010; 5:e14433.
27.
WilseyB, et al.: A randomized, placebo-controlled crossover trial of cannabis cigarettes in neuropathic pain. J Pain, 2008; 9:506–521.
28.
WareMA, et al.: Smoked cannabis for chronic neuropathic pain: A randomized controlled trial. CMAJ, 2010; 182:E694–E701.
